Vandana Singh
·
March 27, 2025
Benzinga
Genmab's Tivdak wins Japan's approval for advanced cervical cancer after a Phase 3 trial showed improved survival over chemotherapy.
read more
April 30, 2025
March 20, 2025
Bloomberg
Financial Times
March 21, 2025